Insulet (PODD) shares of the MedTech name are seeing a strong coiled flag forming after a resurgence this summer following a tough first half of 2024 now positive on the year by +9% and looking ready to run above the 235 level and towards 241.50 short term while a breakout above that monthly value area high would point to the 250 target above. The healthcare and specifically medical equipment stocks are showing great strength this month and look poised to continue. PODD has seen some opening call sales into strength but up at the March $280 call strike and would be a nice target if get to that level from here.